Kernkonzepte
High out-of-pocket costs deter follow-up tests after abnormal mammograms.
Zusammenfassung
The content discusses the financial barriers faced by women with abnormal screening mammograms due to high out-of-pocket costs, hindering necessary follow-up tests. Key points include:
- Federal legislation eliminated cost-sharing for initial breast cancer screening.
- Women with higher cost-sharing have fewer follow-up tests post abnormal mammograms.
- Recommendations include emphasizing the importance of follow-up testing and advocating for legislation to remove out-of-pocket costs.
- Study findings highlight disparities in diagnostic breast imaging based on cost-sharing plans.
- The impact of financial barriers on completing the screening process and health outcomes is concerning.
Statistiken
Plans dominated by coinsurance had the lowest average out-of-pocket costs ($945).
Use of follow-on breast MRI was nearly 24% lower among women in plans with the highest cost-sharing.
Zitate
"The chief clinical implication is that women with abnormal mammograms are deciding not to follow-up on diagnostic imaging because of high out-of-pocket costs." - Danny Hughes, PhD